Related Experiment Video
Updated: Aug 15, 2026

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
Published on: October 27, 2009
Prevention of platelet hyperaggregation during coronary angiography
Insights
Coronary angiography may increase platelet aggregation, posing cardiovascular risks. Ticlopidine, a platelet antiaggregating drug, did not prevent these changes in a small study.
Area of Science:
- Cardiovascular medicine
- Hematology
- Pharmacology
Background:
- Coronary angiography is associated with increased platelet aggregation.
- This aggregation may lead to adverse cardiovascular events, including ventricular fibrillation and death.
- Previous research indicated a need for preventative measures.
Purpose of the Study:
- To investigate the efficacy of ticlopidine in preventing post-coronary angiography platelet aggregation.
- To assess the impact of a pre-procedural antiplatelet regimen on circulating platelet aggregates.
Main Methods:
- A study involving ten patients undergoing coronary angiography.
- Patients received the platelet antiaggregating drug ticlopidine five days prior to the procedure.
- Circulating Platelet Aggregates (CPA) test was used to monitor platelet activity.
Main Results:
- No significant changes were observed in the CPA test results for patients treated with ticlopidine.
- The antiplatelet drug did not appear to inhibit the increase in platelet aggregation post-angiography.
Conclusions:
- Ticlopidine administration prior to coronary angiography did not prevent the expected increase in platelet aggregation.
- Further research is needed to identify effective strategies for mitigating cardiovascular risks associated with coronary angiography.
Abstract:
The authors previously reported an increase in platelet aggregration in the days after coronary angiography, accompanied at times by worrying cardiovascular disorders (ventricular fibrillation in one case, death in two others). In the present study, ten patients received a platelet antiaggregating drug (ticlopidin) 5 days before their coronary angiography. No significant changes were detected in the test for circulating platelet aggregates (CPA test) in these patients.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Peripheral Artery Disease III: Interprofessional Care

